Indeed, when exposing BlCa cells with loss-of-function mutations of KDM6A and SWI/SNF to the EZH2 inhibitor EPZ011989, this resulted in stimulation of NK cells signaling and in tumor cells death. This evidence concerns the gene EZH2 and bladder transitional cell carcinoma.